Sign in

CIK 0001855175

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
271467257
Phone
+1 858-333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,142
in 1 filing, $41K under 10b5-1 plans

Net −$41,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stengone Carmine N. −$41K CEO and President sold 13% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-30 Watkins Tim CMO & Head of Development Option exercise 10b5-1 +10,833 $4.50 $49K 19,794
2026-06-30 Watkins Tim CMO & Head of Development Sale 10b5-1 −10,833 $16.02 $174K 8,961
2026-06-30 Watkins Tim CMO & Head of Development Option exercise · Stock Option (right to buy) 10b5-1 −10,833 238,334
2026-03-02 Watkins Tim CMO & Head of Development Option exercise 10b5-1 +3,611 $4.50 $16K 3,611
2026-03-02 Watkins Tim CMO & Head of Development Sale 10b5-1 −3,611 $15.02 $54K 0
2026-03-02 Watkins Tim CMO & Head of Development Option exercise · Stock Option (right to buy) 10b5-1 −3,611 249,167
2026-01-30 Watkins Tim CMO & Head of Development Grant or award · Stock Option (right to buy) 10b5-1 +160,000 160,000
2026-01-28 Watkins Tim CMO & Head of Development Option exercise 10b5-1 +3,611 $4.50 $16K 3,611
2026-01-28 Watkins Tim CMO & Head of Development Sale 10b5-1 −2,800 $14.09 $39K 811
2026-01-28 Watkins Tim CMO & Head of Development Sale 10b5-1 −811 $14.48 $12K 0
2026-01-28 Watkins Tim CMO & Head of Development Option exercise · Stock Option (right to buy) 10b5-1 −3,611 252,778
2025-12-29 Watkins Tim CMO & Head of Development Option exercise 10b5-1 +3,611 $4.50 $16K 3,611
2025-12-29 Watkins Tim CMO & Head of Development Sale 10b5-1 −3,611 $12.06 $44K 0
2025-12-29 Watkins Tim CMO & Head of Development Option exercise · Stock Option (right to buy) 10b5-1 −3,611 256,389
2025-04-28 Watkins Tim CMO & Head of Development Grant or award · Stock Option (right to buy) +260,000 260,000
2025-04-28 Watkins Tim CMO & Head of Development Grant or award · Stock Option (right to buy) +26,000 26,000

Page 1 of 1 · 16 trades